DNA methylation levels of the ACE2 promoter are not associated with symptoms-severity and related-disability in previously hospitalized COVID-19 survivors.

Fernández-de-Las-Peñas, César; Díaz-Gil, Gema; Gil-Crujera, Antonio; Gómez-Sánchez, Stella M; Ambite-Quesada, Silvia

Fernández-de-Las-Peñas, César; Díaz-Gil, Gema; Gil-Crujera, Antonio; Gómez-Sánchez, Stella M; Ambite-Quesada, Silvia.

Affiliation

Fernández-de-Las-Peñas C; Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos (URJC), Madrid. Spain. Electronic address: cesar.fernandez@urjc.es.
Díaz-Gil G; Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), Madrid. Spain.
Gil-Crujera A; Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), Madrid. Spain.
Gómez-Sánchez SM; Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), Madrid. Spain.
Ambite-Quesada S; Research group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), Madrid. Spain.

Eur J Intern Med ; 2024 Aug 24.

Article in En | MEDLINE | ID: mdl-39183112

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Intern Med Journal subject: MEDICINA INTERNA Year: 2024 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google